Activation of Neuropeptide Y Receptors Modulates Retinal Ganglion Cell Physiology and Exerts Neuroprotective Actions In Vitro

ASN Neuro

Volumn 7, Issue 4, 2015, Pages

  Martins, João ^a,b   Elvas, Filipe ^a,b,c   Brudzewsky, Dan ^a,b,c   Martins, Tânia ^a,b,c   Kolomiets, Bogdan ^d   Tralhão, Pedro ^a,b   Gøtzsche, Casper R ^e   Cavadas, Cláudia ^b,f   Castelo Branco, Miguel ^a,b   Woldbye, David P D ^e   Picaud, Serge ^d   Santiago, Ana R ^a,b,c   Ambrósio, António F ^a,b,c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c ASSOCIATION FOR INNOVATION AND BIOMEDICAL RESEARCH ON LIGHT AND IMAGE AIBILI   (Portugal)

^d SORBONNE UNIVERSITÉ   (France)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

calcium imaging; electrophysiology; neuromodulation; neuropeptide y; retinal explants; retinal ganglion cells

Indexed keywords

CALCIUM; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MESSENGER RNA; NEUROPEPTIDE Y; NEUROPEPTIDE Y (13-36); NEUROPEPTIDE Y RECEPTOR; PEPTIDE FRAGMENT; PROTEIN BINDING; SULFUR; TRANSCRIPTION FACTOR POU4F1;

AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DISEASE MODEL; DRUG EFFECTS; ELECTRORETINOGRAPHY; GENE EXPRESSION REGULATION; GENETICS; LONG EVANS RAT; MALE; METABOLISM; NEWBORN; PATHOLOGY; PATHOPHYSIOLOGY; RAT; RETINA DISEASE; RETINA GANGLION CELL; TUNEL ASSAY; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; CALCIUM; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; GENE EXPRESSION REGULATION; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); IN SITU NICK-END LABELING; MALE; NEUROPEPTIDE Y; PEPTIDE FRAGMENTS; PROTEIN BINDING; RATS; RATS, LONG-EVANS; RATS, WISTAR; RECEPTORS, NEUROPEPTIDE Y; RETINAL DISEASES; RETINAL GANGLION CELLS; RNA, MESSENGER; SULFUR ISOTOPES; TRANSCRIPTION FACTOR BRN-3A;

EID: 84977917067     PISSN: None     EISSN: 17590914     Source Type: Journal    
DOI: 10.1177/1759091415598292     Document Type: Article

References (62)

1. Alvaro, A. R., Martins, J., Araujo, I. M., Rosmaninho-Salgado, J., Ambrosio, A. F., Cavadas, C. (2008a). Neuropeptide Y stimu-lates retinal neural cell proliferation—Involvement of nitric oxide. Journal of Neurochemistry, 105, 2501–2510.
2. Alvaro, A. R., Martins, J., Costa, A. C., Fernandes, E., Carvalho, F., Ambrosio, A. F., …Cavadas, C. (2008b). Neuropeptide Y protects retinal neural cells against cell death induced by ecstasy. Neuroscience, 152, 97–105.
3. 5 receptors. Journal of Neurochemistry, 109, 1508–1515.
4. Alvaro, A. R., Rosmaninho-Salgado, J., Santiago, A. R., Martins, J., Aveleira, C., Santos, P. F., …Cavadas, C. (2007). NPY in rat retina is present in neurons, in endothelial cells and also in microglial and Muller cells. Neurochemistry International, 50, 757–763.
5. Arshavsky, V. Y., Lamb, T. D., & Pugh, E. N. Jr (2002). G proteins and phototransduction. Annual Review of Physiology, 64, 153–187.
6. Babilon, S., Morl, K., & Beck-Sickinger, A. G. (2013). Towards improved receptor targeting: Anterograde transport, internaliza-tion and postendocytic trafficking of neuropeptide Y receptors. Biological Chemistry, 394, 921–936.
7. Barres, B. A., Silverstein, B. E., Corey, D. P., & Chun, L. L. (1988). Immunological, morphological, and electrophysiological variation among retinal ganglion cells purified by panning. Neuron, 1, 791–803.
8. Benarroch, E. E. (2009). Neuropeptide Y: Its multiple effects in the CNS and potential clinical significance. Neurology, 72, 1016–1020.
9. Bitran, M., Tapia, W., Eugenin, E., Orio, P., & Boric, M. P. (1999). Neuropeptide Y induced inhibition of noradrenaline release in rat hypothalamus: Role of receptor subtype and nitric oxide. Brain Research, 851, 87–93.
10. 2 receptor. British Journal of Pharmacology, 103, 1781–1789.
11. Bleakman, D., Harrison, N. L., Colmers, W. F., & Miller, R. J. (1992). Investigations into neuropeptide Y-mediated presynap-tic inhibition in cultured hippocampal neurones of the rat. British Journal of Pharmacology, 107, 334–340.
12. Bruun, A., Edvinsson, L., & Ehinger, B. (1994). Neuropeptide Y inhibits adenylyl cyclase activity in rabbit retina. Acta Ophthalmologica (Copenhagen), 72, 326–331.
13. Bruun, A., & Ehinger, B. (1993). NPY-induced neurotransmitter release from the rabbit and chicken retina. Acta Ophthalmologica (Copenhagen), 71, 590–596.
14. Canto Soler, M. V., Gallo, J. E., Dodds, R. A., Hokfelt, T., Villar, M. J., Suburo, A. M. (2002). Y1 receptor of neuropeptide Y as a glial marker in proliferative vitreoretinopathy and diseased human retina. Glia, 39, 320–324.
15. Chambers, A. P., & Woods, S. C. (2012). The role of neuropeptide Y in energy homeostasis. Handbook of Experimental Pharmacology, 209, 23–45.
16. Christensen, D. Z., Olesen, M. V., Kristiansen, H., Mikkelsen, J. D., & Woldbye, D. P. (2006). Unaltered neuropeptide Y (NPY)-stimulated [35S]GTPgammaS binding suggests a net increase in NPY signalling after repeated electroconvulsive seizures in mice. Journal of neuroscience research, 84, 1282–1291.
17. 2þ influx into rod bipolar cell terminals. Neuroscience, 125, 1039–1049.
18. 1 immunoreac-tive cells. Journal of Comparative Neurology, 454, 373–382.
19. Dimitrijevic, M., & Stanojevic, S. (2013). The intriguing mission of neuropeptide Y in the immune system. Amino Acids, 45, 41–53.
20. El Bahh, B., Cao, J. Q., Beck-Sickinger, A. G., & Colmers, W. F. (2002). Blockade of neuropeptide Y(2) receptors and suppression of NPY’s anti-epileptic actions in the rat hippocampal slice by BIIE0246. British Journal of Pharmacology, 136, 502–509.
21. Endoh, T., Nobushima, H., & Tazaki, M. (2012). Neuropeptide Y modulates calcium channels in hamster submandibular ganglion neurons. Neuroscience Research, 73, 275–281.
22. Gollisch, T., & Meister, M. (2010). Eye smarter than scientists believed: Neural computations in circuits of the retina. Neuron, 65, 150–164.
23. Goodyear, E., & Levin, L. A. (2008). Model systems for experimental studies: Retinal ganglion cells in culture. Progress in Brain Research, 173, 279–284.
24. Hartwick, A. T., Hamilton, C. M., & Baldridge, W. H. (2008). Glutamatergic calcium dynamics and deregulation of rat retinal ganglion cells. The Journal of Physiology, 586, 3425–3446.
25. Hartwick, A. T., Lalonde, M. R., Barnes, S., & Baldridge, W. H. (2004). Adenosine A1-receptor modulation of glutamate-induced calcium influx in rat retinal ganglion cells. Investigative Ophthalmology and Visual Science, 45, 3740–3748.
26. Hastings, J. A., McClure-Sharp, J. M., & Morris, M. J. (2001). NPY Y1 receptors exert opposite effects on corticotropin releasing factor and noradrenaline overflow from the rat hypothalamus in vitro. Brain Research, 890, 32–37.
27. 1 receptor effects on noradrenaline overflow from the rat brain in vitro. Regulatory Peptides, 120, 107–112.
28. Higgs, M. H., & Lukasiewicz, P. D. (1999). Glutamate uptake limits synaptic excitation of retinal ganglion cells. Journal of Neuroscience, 19, 3691–3700.
29. Hirsch, D., & Zukowska, Z. (2012). NPY and stress 30 years later: The peripheral view. Cellular and Molecular Neurobiology, 32, 645–659.
30. Kovac, S., Megalogeni, M., & Walker, M. (2011). In vitro effects of neuropeptide Y in rat neocortical and hippocampal tissue. Neuroscience Letters, 492, 43–46.
31. Lagreze, W. A., Knorle, R., Bach, M., & Feuerstein, T. J. (1998). Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Investigative Ophthalmology and Visual Science, 39, 1063–1066.
32. Lee, N. J., & Herzog, H. (2009). NPY regulation of bone remodel-ling. Neuropeptides, 43, 457–463.
33. Malva, J. O., Xapelli, S., Baptista, S., Valero, J., Agasse, F., Ferreira, R., …Silva, A. P. (2012). Multifaces of neuropeptide Y in the brain—Neuroprotection, neurogenesis and neuroin-flammation. Neuropeptides, 46, 299–308.
34. Meister, M., Pine, J., & Baylor, D. A. (1994). Multi-neuronal sig-nals from the retina: Acquisition and analysis. Journal of Neuroscience Methods, 51, 95–106.
35. Michel, M. C., Beck-Sickinger, A., Cox, H., Doods, H. N., Herzog, H., Larhammar, D, …Westfall, T. (1998). XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide, Y, peptide, YY, and pancreatic polypeptide receptors. Pharmacological Reviews, 50, 143–150.
36. Milenkovic, I., Weick, M., Wiedemann, P., Reichenbach, A., & Bringmann, A. (2004). Neuropeptide Y-evoked proliferation of retinal glial (Muller) cells. Graefe’s Archive for Clinical and Experimental Ophthalmology, 242, 944–950.
37. Nadal-Nicolas, F. M., Jimenez-Lopez, M., Salinas-Navarro, M., Sobrado-Calvo, P., Alburquerque-Bejar, J. J., Vidal-Sanz, M., …Agudo-Barriuso, M. (2012). Whole number, distribution and co-expression of brn3 transcription factors in retinal ganglion cells of adult albino and pigmented rats. PloS One, 7, e49830.
38. Oh, S. J., D’Angelo, I., Lee, E. J., Chun, M. H., & Brecha, N. C. (2002). Distribution and synaptic connectivity of neuropeptide Y-immunoreactive amacrine cells in the rat retina. Journal of Comparative Neurology, 446, 219–234.
39. Osborne, N. N., Casson, R. J., Wood, J. P., Chidlow, G., Graham, M., Melena, J. (2004). Retinal ischemia: Mechanisms of damage and potential therapeutic strategies. Progress in Retinal and Eye Research, 23, 91–147.
40. Peng, P. H., Chao, H. M., Juan, S. H., Chen, C. F., Liu, J. H., Ko, M. L. (2011). Pharmacological preconditioning by low dose cobalt protoporphyrin induces heme oxygenase-1 overexpres-sion and alleviates retinal ischemia-reperfusion injury in rats. Current Eye Research, 36, 238–246.
41. Perney, T. M., & Miller, R. J. (1989). Two different G-proteins mediate neuropeptide Y and bradykinin-stimulated phospho-lipid breakdown in cultured rat sensory neurons. The Journal of Biological Chemistry, 264, 7317–7327.
42. 5 receptor activation and lipid accumulation in murine adipocytes. Neuropeptides, 46, 359–366.
43. Santos-Carvalho, A., Alvaro, A. R., Martins, J., Ambrosio, A. F., & Cavadas, C. (2014). Emerging novel roles of neuropeptide Y in the retina: From neuromodulation to neuroprotection. Progress in Neurobiology, 112, 70–79.
44. 2 are present in neurons and glial cells in rat retinal cells in culture. Investigative Ophthalmology and Visual Science, 54, 429–443.
45. Santos-Carvalho, A., Elvas, F., Alvaro, A. R., Ambrosio, A. F., & Cavadas, C. (2013a). Neuropeptide Y receptors activation protects rat retinal neural cells against necrotic and apoptotic cell death induced by glutamate. Cell Death Disease, 4, e636.
46. Shen, Y., Liu, X. L., & Yang, X. L. (2006). N-methyl-D-aspartate receptors in the retina. Molecular Neurobiology, 34, 163–179.
47. Silva, A. P., Cavadas, C., & Grouzmann, E. (2002). Neuropeptide Y and its receptors as potential therapeutic drug targets. Clinica Chimica Acta, 326, 3–25.
48. Silva, A. P., Pinheiro, P. S., Carvalho, A. P., Carvalho, C. M., Jakobsen, B., Zimmer, J., …Malva, J. O. (2003). Activation of neuropeptide Y receptors is neuroprotective against excito-toxicity in organotypic hippocampal slice cultures. FASEB Journal, 17, 1118–1120.
49. Silva, A. P., Xapelli, S., Grouzmann, E., & Cavadas, C. (2005). The putative neuroprotective role of neuropeptide Y in the central nervous system. Current drug targets. CNS and neurological disorders, 4, 331–347.
50. Sinclair, J. R., Jacobs, A. L., & Nirenberg, S. (2004). Selective ablation of a class of amacrine cells alters spatial processing in the retina. The Journal of Neuroscience, 24, 1459–1467.
51. 5 receptor agonists in vitro and in vivo. Neuropeptides, 43, 235–249.
52. Sousa-Ferreira, L., Garrido, M., Nascimento-Ferreira, I., Nobrega, C., Santos-Carvalho, A., Alvaro, A. R., …Cavadas, C. (2011). Moderate long-term modulation of neuropeptide Y in hypothal-amic arcuate nucleus induces energy balance alterations in adult rats. PloS One, 6, e22333.
53. Straznicky, C., & Hiscock, J. (1989). Neuropeptide Y-like immu-noreactivity in neurons of the human retina. Vision Research, 29, 1041–1048.
54. 2þ channels in acutely isolated neurons from the rat arcuate nucleus. Journal of Neurophysiology, 81, 1391–1403.
55. Thoreson, W. B., & Witkovsky, P. (1999). Glutamate receptors and circuits in the vertebrate retina. Progress in Retinal and Eye Research, 18, 765–810.
56. Tornqvist, K., & Ehinger, B. (1988). Peptide immunoreactive neurons in the human retina. Investigative Ophthalmology & Visual Science, 29, 680–686.
57. 2 receptor plasticity. Neuroscience, 143, 1085–1094.
58. 2þ entry in the rat cerebral cortex nerve terminals: Suppression of this inhibitory effect by the protein kinase C-dependent facilitatory pathway. Neuroscience, 134, 987–1000.
59. Wassle, H., & Boycott, B. B. (1991). Functional architecture of the mammalian retina. Physiological Reviews, 71, 447–480.
60. Xapelli, S., Silva, A. P., Ferreira, R., & Malva, J. O. (2007). Neuropeptide Y can rescue neurons from cell death following the application of an excitotoxic insult with kainate in rat orga-notypic hippocampal slice cultures. Peptides, 28, 288–294.
61. Yannielli, P., & Harrington, M. E. (2004). Let there be ‘‘more’’ light: Enhancement of light actions on the circadian system through non-photic pathways. Progress in Neurobiology, 74, 59–76.
62. Zhang, Z., Qin, X., Zhao, X., Tong, N., Gong, Y., Zhang, W., …Wu, X. (2012). Valproic acid regulates antioxidant enzymes and prevents ischemia/reperfusion injury in the rat retina. Current Eye Research, 37, 429–437.